The U.S. Food and Drug Administration has approved Swedish drugmaker Orexo AB's drug to treat opioid addiction. The tablet, Zubsolv, combines the drugs buprenorphine and naloxone and will compete with similar products, Subutex and Suboxone, made by Britain's Reckitt-Benckiser Group Plc. Read the full story